The high frequency of anti-PF4/heparin antibodies in patients with COVID-19 is neither related to heparin treatment or to an increased incidence of thrombosis.
2021
Keywords:
-
Correction
-
Source
-
Cite
-
Save
8
References
2
Citations
NaN
KQI